Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Hypertension. 2019 Jan;73(1):60–67. doi: 10.1161/HYPERTENSIONAHA.118.11691

Table 3:

Results of univariable and multivariable hierarchical logistic regression models for all-cause 30-day readmission

Covariates Unadjusted OR (95% CI) p-value Adjusted OR (95% CI)* p-value
Age<65 years 1.02 (1.00–1.05) 0.10 1.21 (1.17–1.25) <0.001
Female sex 1.10 (1.07–1.13) <0.001 1.09 (1.07–1.12) <0.001
Primary payer
Medicare Reference Reference
Medicaid 1.15 (1.11–1.20) <0.001 1.05 (1.002–1.10) 0.04
Private insurance 0.54 (0.52–0.56) <0.001 0.63 (0.60–0.66) <0.001
Self-pay 0.51 (0.48–0.55) <0.001 0.61 (0.57–0.66) <0.001
No charge 0.50 (0.42–0.59) <0.001 0.61 (0.51–0.72) <0.001
Other 0.66 (0.60–0.72) <0.001 0.71 (0.65–0.78) <0.001
Missing 0.53 (0.35–0.81) <0.001 0.57 (0.37–0.86) 0.008
Income quartile of patient’s ZIP code
First Reference Reference
Second 0.92 (0.89–0.95) <0.001 0.97 (0.94–1.00) 0.06
Third 0.88 (0.85–0.91) <0.001 0.95 (0.91–0.99) 0.007
Fourth 0.83 (0.79–0.87) <0.001 0.93 (0.89–0.97) 0.002
Missing 0.87 (0.78–0.97) 0.01 0.94 (0.84–1.04) 0.23
Hospital characteristics
Hospital bedsize
Small Reference Reference
Medium 1.09 (1.02 – 1.15) 0.007 1.05 (0.99–1.11) 0.08
Large 1.11 (1.05–1.17) <0.001 1.07 (1.01–1.12) 0.02
Teaching status
Metropolitan nonteaching Reference Reference
Metropolitan teaching 0.97 (0.93–1.00) 0.07 0.98 (0.95–1.02) 0.36
Nonmetropolitan hospital 0.89 (0.84–0.95) <0.001 0.94 (0.88–1.00) 0.054
Hospital control
Government, nonfederal Reference Reference
Private, not-for-profit 1.04 (0.98–1.10) 0.19 1.01 (0.96–1.06) 0.78
Private, investor-owned 1.14 (1.07–1.22) <0.001 1.10 (1.03–1.16) 0.003
Comorbidities
DM with complications 1.64 (1.59–1.70) <0.001 1.20 (1.16–1.24) <0.001
Chronic kidney disease 1.85 (1.81–1.90) <0.001 1.20 (1.16–1.24) <0.001
End-stage renal disease 2.21 (2.14–2.29) <0.001 1.46 (1.41–1.52) <0.001
Valvular heart disease 1.11 (1.05–1.16) <0.001 1.03 (0.98–1.09) 0.29
Obesity 0.89 (0.86–0.91) <0.001 0.86 (0.83–0.89) <0.001
Peripheral vascular disease 1.28 (1.24–1.33) <0.001 1.10 (1.06–1.15) <0.001
Chronic lung disease 1.44 (1.40–1.48) <0.001 1.19 (1.16–1.23) <0.001
Pulmonary circulation disease 1.37 (1.30–1.45) <0.001 1.09 (1.03–1.16) 0.003
Chronic liver disease 1.63 (1.52–1.75) <0.001 1.27 (1.18–1.37) <0.001
Coagulopathy 1.24 (1.18–1.31) <0.001 1.02 (0.97–1.08) 0.41
Drug abuse 1.37 (1.30–1.44) <0.001 1.32 (1.25–1.40) <0.001
Charlson comorbidity index >3 1.93 (1.88–1.98) <0.001 1.25 (1.21–1.29) <0.001
End-organ involvement
Acute or unspecified heart failure 1.92 (1.87–1.98) <0.001 1.37 (1.32–1.42) <0.001
Acute myocardial infarction 0.95 (0.91–0.98) 0.004 1.00 (0.96–1.04) 0.87
Stroke or transient ischemic attack 0.54 (0.52–0.56) <0.001 0.76 (0.73–0.80) <0.001
Length of stay > median 1.44 (1.40–1.47) <0.001 1.25 (1.22–1.29) <0.001
Disposition
Routine Reference Reference
Transfer to short-term hospital 1.48 (1.33–1.64) <0.001 1.60 (1.44–1.78) <0.001
Transfer to skilled nursing facility or intermediate care facility 1.35 (1.31–1.39) <0.001 1.29 (1.24–1.33) <0.001
Home healthcare 1.36 (1.32–1.41) <0.001 1.24 (1.20–1.28) <0.001
Discharge against medical advice 2.44 (2.24–2.66) <0.001 2.20 (2.01–2.40) <0.001
Unknown 0.31 (0.16–0.61) <0.001 0.34 (0.17–0.68) 0.002

*AIC for full model – AIC for null model= –7404.3, BIC for full model – BIC for null model= –7013.5. Differences in AIC and BIC for full model versus null model indicate very strong support for the full model. Likelihood ratio test showed a statistically significant improvement in model fit (p<0.001) for the full model compared with the null model.

AIC: Akaike Information Criterion, BIC: Bayesian Information Criterion